Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Latin America is a key pharmaceutical and healthcare market. The region's growing economies, coupled with an ageing population and increased life expectancy across the board, translate to an ever-growing demand for medicine and health-related ...
View more details
In 2024-2025, Brazil witnessed significant investments in its pharmaceutical and healthcare sector. Specifically, the Brazilian National Development Bank (BNDES) allocated record-high loans to domestic pharmaceutical manufacturing firms Ache and ...
View more details
Brazil is the largest pharmaceutical market in Latin America, with retail drug sales of USD 27.1bn for the 12 months ending in June 2022. Brazil's pharmaceutical and healthcare sectors are transitioning into the post-pandemic period with some ...
View more details
Brazil's pharmaceutical and healthcare sector is navigating the post-pandemic period with some positives but also quite a few challenges. Among the positives is a sharp rise in public health spending observed in 2021-2023 compared to the pre-pandemic ...
View more details
Brazil is the largest pharmaceutical market in Latin America, with retail drug sales of USD 33.1bn in 2022. Brazil's pharmaceutical and healthcare sector faced several challenges during the COVID-19 pandemic, including shortages of drugs and active ...
View more details
Brazil's pharmaceutical and healthcare sector encountered problems during the COVID-19 pandemic, including shortages of drugs and active pharmaceutical ingredients (APIs), rapid price increases for pharmaceutical products and strained finances in the ...
View more details
The COVID-19 pandemic underlined the inefficiencies of the Brazilian pharmaceutical and healthcare sector. In drug manufacturing, many pharmaceutical companies took a hit in profitability. They struggled to meet demand as global supply chains were ...
View more details
Latin America was among the hardest-hit regions by the COVID-19 pandemic. The novel coronavirus entered the region at a bad time. The commodities boom at end of the 2000s combined with several local crises afterwards have hurt badly the public ...
View more details